Fulgent Genetics

In News

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 46% Potential Upside Amid Diagnostic and Therapeutic Growth - DirectorsTalk Interviews

DirectorsTalk Interviews - Feb 13, 2026

Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Zacks Research - MarketBeat

MarketBeat - Feb 11, 2026

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 - Yahoo Finance Singapore

Yahoo Finance Singapore - Feb 12, 2026

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 - Caledonian Record

Caledonian Record - Feb 12, 2026

Latham & Watkins Advises on Fulgent Genetics’ Acquisition of Bako Diagnostics and StrataDX - Latham & Watkins LLP

Latham & Watkins LLP - Dec 22, 2025

Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock - Seeking Alpha

Seeking Alpha - Jan 27, 2026

FLGT to acquire Bako & StrataDx assets to expand pathology platform - MSN

MSN - Feb 09, 2026

Earnings call transcript: Fulgent Genetics Q3 2025 Surpasses EPS Expectations - Investing.com

Investing.com - Nov 07, 2025

What Does The Institutional Ownership Tell Us About Fulgent Genetics? - simplywall.st

simplywall.st - Jan 30, 2026

Why Fulgent Genetics Stock Was Crushing It on Friday - The Motley Fool

The Motley Fool - Aug 01, 2025

Fulgent Genetics to buy Bako Diagnostics assets and StrataDx - Medical Device Network

Medical Device Network - Dec 23, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

MarketBeat - Feb 07, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment